Experts skeptical after researchers report positive vaccine results

China's first coronavirus vaccine trial leaves some experts skeptical.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

The United States should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the White House Coronavirus Task Force, said Tuesday.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
The Trump administration chose 5 companies as the most likely to produce a vaccine. The tally of new cases is rising in the U.S., partly because of expanded testing. Italy ends travel restrictions.
Source: NYT Health - Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news
A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the U.S. population by the end of the year.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The Trump administration has selected five companies, including Moderna Inc, AstraZeneca Plc and Pfizer Inc, as the most likely candidates to produce a vaccine for the novel coronavirus, the New York Times reported on Wednesday, citing senior officials.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Turkey’s health minister says Turkey and Russia have agreed to cooperate in the development of a coronavirus vaccine and plan to carry out joint clinical trials
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Brazil's health regulator Anvisa has approved human clinical trials for a potential coronavirus vaccine developed by scientists at Oxford University and supported by AstraZeneca Plc, it said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Conclusion Medical device specialists want to help, but responding to pandemic shortages can be complicated. These takeaways come from our experience with building PPE, but they apply to any collaborative rapid response project. Use these tips as a framework to get you and your team on the path to meaningful progress.
Source: MDDI - Category: Medical Devices Authors: Tags: Design Source Type: news
The nation that produces the first safe and effective vaccine will gain not only bragging rights but also a fast track to put its people back to work, a powerful public health tool to protect its citizens and a precious resource to reward allies.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
Brazil this month will start testing an experimental vaccine against the novel coronavirus being developed by researchers at the University of Oxford and AstraZeneca Plc, Brazil's health surveillance agency Anvisa and the Federal University of Sao Paulo (Unifesp) said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: China Health | Coronavirus | COVID-19 | Health | Vaccines